Literature DB >> 20383878

Retraction. CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells.

.   

Abstract

Entities:  

Year:  2010        PMID: 20383878      PMCID: PMC4508331          DOI: 10.1182/blood-2010-03-273136

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Therapeutic monoclonal antibodies for multiple myeloma: an update and future perspectives.

Authors:  Jing Yang; Qing Yi
Journal:  Am J Blood Res       Date:  2011-06-15

2.  Independent validation of induced overexpression efficiency across 242 experiments shows a success rate of 39.

Authors:  Gyöngyi Munkácsy; Péter Herman; Balázs Győrffy
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

Review 3.  Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives.

Authors:  S Lonial; B Durie; A Palumbo; J San-Miguel
Journal:  Leukemia       Date:  2015-08-12       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.